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Purpose: To compare peripapillary retinal nerve fiber layer thickness 
(RNFLT) between patients with multiple sclerosis (MS) and healthy 
controls using optical coherence tomography (OCT).
Patients and Methods: In this prospective case control study, peripapillary 
RNFLT of 120 eyes from 60 patients with multiple sclerosis (MS)  was 
compared to 120 eyes from 60 age and sex matched healthy controls using 
OCT. The RNFLT in 4 peripapillary quadrants and the mean RNFLT of all 
four quadrants were compared between the case and control groups. The 
relation between MS variables such as age of onset, type and duration of 
disease, history of optic neuritis (ON) and other non-ocular episodes with 
RNFLT was evaluated in the case group.
Results: The mean RNFLT of all four quarters was significantly lower in 
patients with MS compared to the controls (P < 0.001). Also RNFLT was 
significantly lower in each of 4 quadrants (superior, temporal, inferior; 
P < 0.001, nasal P = 0.003). There was no significant relation between 
RNFLT, the age of onset of MS disease, and history of non-ocular episodes. 
RNFLT had a significant relation with duration of the disease (P < 0.001), 
the type of MS (P < 0.001), history of ON (P = 0.002), and the number of 
ON episodes (P = 0.021).  
Conclusion: We found that RNFLT decreases in MS patients and its 
reduction is related to the duration and type of disease as well as history 
and number of ON episodes. Therefore measuring RNFLT may help in 
estimating the progress of MS and can potentially be included as a part of 
patients’ follow up protocol.
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Introduction
Multiple sclerosis (MS) is a primary 
demyelinating disease of the central nervous 
system (CNS) with a variety of clinical 
presentations. While myelin damage is the 
hallmark of MS, axonal degeneration is the final 
pathologic process, which leads to irreversible 
disabilities 1. Therefore, evaluation of CNS 
axonal function is of value for assessment of 
the course of the disease and prognosis among 
MS patients. 
Retinal nerve fiber layer (RNFL), which is 
the unmyelinated extension of the optic nerve, 
represents a part of CNS and the thickness of this 
layer is associated with changes in CNS axonal 
function 2-4. Optical coherence tomography 
(OCT) is a noninvasive imaging technique 
that provides high-resolution cross-sectional 
images of the retina and automatic measurement 
of retinal thickness as well as retinal nerve 
fiber layer thickness (RNFLT). Because retina 
contains axons and glia without myelin and 
originates from CNS, RNFLT is valued as a 
sensitive and also non-invasive quantification 
of neurodegeneration and is used in evaluation 
of neurological disorders especially MS 3-6. 
OCT was initially used for assessing changes 
in glaucoma and macular disorders 6, but at 
present it is used in evaluating neurological 
disorders such as MS 5, 7-11, Alzheimer’s disease 
12, Parkinson’s disease 13, schizophrenia 14, and 
bipolar disease 15. OCT measurements of RNFLT 
have also provided a window to follow the CNS 
axonal and neuronal loss in MS patients 2,16,17. 
In the present study, we compared peripapillary 
RNFLT between patients with MS and healthy 
controls using optical coherence tomography 
(OCT) to evaluate the use of OCT as a 
monitoring tool of disease progression.
Patients and Methods
This prospective case-control study was carried 
out from July 2012 to December 2015. Sixty 
patients with diagnosis of MS were recruited 
from the neurology clinic of Imam Hossein 
Medical Center, Tehran, Iran, and entered 
the study as the case group. Also 60 controls 
were recruited from the healthy persons 
accompanying the patients in outpatient 
ophthalmology ward of the same hospital. The 
protocol was approved by the ethics committee 
of Shahid Beheshti University of Medical 
Sciences, Tehran, Iran, and the study followed 
the tenets of the Declaration of Helsinki. 
Informed written consent was obtained from 
all participants prior to entering the study. 
All patients with a history of neurologic 
and systemic diseases other than MS were 
excluded from the present study. Other 
exclusion criteria were significant refractive 
error, abnormal IOP, history of amblyopia, 
history of any retinal pathology other than 
MS, and corneal haziness. Also to eliminate 
the effect of acute inflammatory process on 
RNFLT, patients were excluded if less than 
3 months had passed from their last optic 
neuritis (ON) attack.
The patients with MS underwent a complete 
neurological examination and definite MS 
diagnosis was based on McDonald criteria 18. 
Variables such as age of onset, type of disease 
and its duration as well as history of ON and 
other non-ocular episodes were recorded 
for all patients with MS entering the study. 
ON was diagnosed based on precise history 
taking or documented previous examinations. 
Also the cases and controls underwent a 
complete ophthalmologic examination, 
including assessment of best-corrected visual 
acuity (BCVA), intraocular pressure (IOP) 
measurement, slit lamp biomicroscopy, and 
dilated fundus examination. Measurement 
of peripapillary RNFLT was performed 
for all participants in the study using OCT 
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(3D OCT-1000, Topcon Corporation, Tokyo, 
Japan) method. OCT was performed by an 
experienced optometrist who was masked 
to the participants’ diagnosis. Scans with a 
quality factor lower than 60 and blinking 
during the scanning process were excluded. 
OCT was performed for every eye in a 3.4 
mm wide circle around the optic disc in 
four superior, temporal, inferior and nasal 
quadrants. The thickness of each quadrant and 
the mean thickness of all four quadrants were 
used for analysis. 
Statistical method
To present data, we used mean, standard 
deviation, median, range, percent and 
frequency. To compare the characteristics of 
the case and control groups we used t-test 
and Chi-Square test. To compare the RNFLT 
between the study groups we used generalized 
estimating equation (GEE) analysis. Also 
another GEE model was used to compare the 
groups adjusted for the age and gender. All 
statistical analysis was performed using SPSS 
Version 22 (Armonk, NY: IBM Corp.). All 
tests were two sided and a P value of less than 
0.05 was considered statistically significant.
Results
In this prospective comparative case control 
study, we compared 120 eyes of 60 patients 
with diagnosis of MS to 120 eyes of 60 age 
and sex matched healthy individuals. The 
mean age of participants was 33 ± 10 and 
34 ± 10 years in the case and control groups 
respectively. Ninety percent of both groups 
were female and 10 % were male (Table 1). 
Thirty six (60 %) MS patients had a disease 
duration of more than five years and only 7 
(11.7 %) had disease duration of less than one 
year. Also sixty three percent of MS patients 
had a history of at least one ON attack with 
thirteen cases (21.7 %) experiencing ON in 
both eyes (Table 2).
The mean RNFLT of four quadrants was 
significantly lower in cases (90 ± 12 μm) 
compared to the controls (102 ± 9 μm) 
(P < 0.001) (Table 3). Also the mean RNFLT 
in each individual quadrant was significantly 
lower among cases in comparison to the 
controls (superior, temporal, inferior; 
P < 0.001, nasal P = 0.003) (Table 3).





Age Mean ± SD 33 ± 10 33 ± 10 34 ± 10 0.859*
Median (range) 31 (15 to 68) 33 (19 to 68) 31 (15 to 57)
≤ 30 112 (46.7 %) 56 (46.7 %) 56 (46.7 %)
31-45 92 (38.3 %) 46 (38.3 %) 46 (38.3 %)
≥ 46 36 (15.0 %) 18 (15.0 %) 18 (15.0 %)
Sex Female 216 (90.0 %) 108 (90.0 %) 108 (90.0 %) 1†
Male 24 (10.0 %) 12 (10.0 %) 12 (10.0 %)
* Based on t-test.
† Based on Chi-square test.
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There was no statically significant relation 
between RNFLT and the age of onset of 
MS disease (0.155) (Table 4). RNFLT had 
a statistically significant relation with the 
duration of the disease and patients with 
disease duration of more than 1 year had 
thinner RNFLT than those with disease 
duration of less than one year (P < 0.001) 
(Table 4). Also patients with secondary 
progressive MS had thinner RNFLT compared 
to those with other types of the disease 
(P < 0.001) (Table 4). Cases with a history 
of ON had thinner RNFLT (90 ± 13 μm) 
compared to those without a history of ON 
(95 ± 11 μm) (P = 0.002), and the number of ON 
episodes also showed a statistically significant 
relation with RNFLT (P = 0.021) (Table 4). 
Twenty three cases (38.3 %) had ON only 
in one eye.  Among these patients the mean 
RNFLT was 83 ±12 μm for affected eye versus 
97 ± 10 μm for the unaffected eyes (P < 0.001) 
(Table 4). No significant relation was observed 
between RNLFT and non-ocular episodes 
(P = 0.286) (Table 4). 
Discussion
Evaluation of patients with demyelinating 
disease requires a reliable and sensitive 
imaging technique to investigate specific 
pathologic changes of the CNS 19. These 
patients are routinely followed by size and 
number of the lesions in brain and spinal 
cord MRI, but there is no absolute correlation 
between disease severity and the extent of these 
lesions 11. Therefore MRI is not necessarily an 
appropriate tool for patients follow up and 
prediction of disease progress 11. Optic nerve 
involvement in form of ON is a common 
presentation of demyelinating diseases which 
occurs in 30-70 % of MS patients and may 
affect RNFLT 12,13. Therefore assessment of 
RNFLT may provide useful information about 
Table 2:  Disease variables among 
patients with MS
Parameter   
Age of onset Mean ± SD 27 ± 9
Median (range) 26 (16 to 55)
≤ 25 30 (50.0 %)
26-40 25 (41.7 %)
≥ 41 5 (8.3 %)
Duration Less than 1 
year
7 (11.7 %)
1-5 year 17 (28.3 %)
More than 5 36 (60.0 %)
MS Type* RRMS 51 (85.0 %)
PPMS 5 (8.3 %)
SPMS 2 (3.3 %)
PRMS 2 (3.3 %)
Non-Ocular 
Episodes
Mean ± SD 2.3 ± 2.7
Median (range) 1 (0 to 15)
Number 0 11 (18.3 %)
1 21 (35.0 %)
2 - 4 19 (31.7 %)
≥ 5 9 (15.0 %)
Ocular 
Episodes (ON)
Mean ± SD 0.9 ± 1.1
Median (range) 1 (0 to 7)
Number 0 22 (36.7 %)
1 30 (50.0 %)
≥ 2 8 (13.3 %)
Medicine Rebif 8 (13.3 %)
ReciGen 0 (0.0 %)
Avonex 4 (6.7 %)
CinnoVex 20 (33.3 %)
Betaferon 9 (15.0 %)
Others 10 (16.7 %)
None 9 (15.0 %)
Mean ± SD 0.01 ± 0.03
BCVA 
LogMAR
Median (range) 0 (0 to 0.2)
10/10 75 (84.3 %)
< 10/10 14 (15.7 %)
RRMS: Relapsing remitting multiple sclerosis 
PPMS: Primary progressive multiple sclerosis 
SPMS: Secondary progressive multiple sclerosis
PRMS: Progressive relapsing multiple sclerosis
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CNS axonal damage and has the potential 
to become a practical means of evaluating 
MS progression 7,8. RNFLT can be directly 
visualized using OCT which is a noninvasive, 
convenient, fast, and precise technique. 
According to the results of the present study, 
MS patients, with or without a history of ON, 
had significant thinning of RNFL measured 
by OCT compared to normal individuals. 
Patients with disease duration of 1 to 5 years 
showed more thinning of RNFL compared to 
those patients with disease duration of less 
than one year. Patients with history of ON 
had significantly thinner RNFL compared to 
those without ON episodes and RNFLT also 
correlated with the number of ON episodes. 
In addition, patients with a history ON in one 
eye had thinner RNFL in the affected eye 
compared to unaffected eye. Finally patients 
with secondary progressive MS had thinner 
RNFLT compared to those with other types of 
the disease. 
Similar to our findings some previous studies 
have shown that subclinical RNFL thinning 
occurs in MS 21. Frohman et al., 3  found that 
there is a strong association between RNFLT 
and low contrast visual acuity in MS 3. Spain et 
al., 20 found an association between MS duration 
with both RNFLT and the expanded disability 
status scale (EDSS), but the relation was not 
statistically significant.  In another study by 
Singer et al., 22 the mean RNFL thickness in 
MS patients was lower than normal controls 
and the degree of RNFL thinning was related 
to the amount of lesions detected in MRI T1 
sequence. They also reported that RNFLT was 
Table 3: Comparison of  RNFLT  between the case and control groups
Quadrant  Total
Groups
P value* P value**
MS Control
Superior Mean ± SD 118 ± 18 111 ± 18 124 ± 14 0.000 < 0.001
Median 
(range)
119 (56 to 162) 115 (56 to 143) 123 (84 to 162)
Nasal Mean ± SD 80 ± 16 76 ± 15 83 ± 16 0.004 0.003
Median 
(range)
79 (33 to 146) 75 (33 to 116) 82 (52 to 146)
Inferior Mean ± SD 118 ± 19 108 ± 18 127 ± 14 0.000 < 0.001
Median 
(range)
120 (54 to 155) 110 (54 to 147) 129 (95 to 155)
Temporal Mean ± SD 68 ± 13 64 ± 14 73 ± 11 0.000 < 0.001
Median 
(range)
68 (34 to 99) 62 (34 to 99) 71 (55 to 99)
The Mean of all 
four quadrants




97 (60 to 134) 92 (60 to 114) 102 (80 to 134)   
 * Based on GEE analysis
 ** Adjusted for age and sex, based on GEE analysis
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Table 4: The relation between MS variables and  RNFLT




P value* Mean ± 
SD
P value* Mean ± 
SD
P value* Mean ± 
SD
P value* Mean ± 
SD
P value*
Age of  
Onset
<= 25 109 ± 20 0.235 79 ± 15 0.171 106 ± 19 0.482 63 ± 14 0.336 89 ± 14 0.155
26-40 116 ± 17 85 ± 12 111 ± 13 65 ± 13 94 ± 10
41+ 118 ± 11 80 ± 14 106 ± 18 67 ± 19 93 ± 14
Duration less than 1 
year
128 ± 8 0.004 91 ± 12 0.009 118 ± 12 0.153 74 ± 11 0.007 103 ± 6 < 0.001
1-5 year 114 ± 18 79 ± 13 109 ± 15 61 ± 12 91 ± 12
more than 5 109 ± 19 81 ± 14 106 ± 18 64 ± 15 90 ± 13
MS Types† RRMS 113 ± 18 0.297 81 ± 14 0.545 108 ± 16 < 0.001 65 ± 14 < 0.001 92 ± 13 < 0.001
PPMS 120 ± 20 84 ± 15 112 ± 15 68 ± 10 96 ± 14
SPMS 89 ± 27 77 ± 4 88 ± 25 50 ± 10 76 ± 16




Yes 110 ± 19 0.011 80 ± 14 0.004 106 ± 18 0.016 62 ± 14 0.035 90 ± 13 0.002
No 118 ± 17 83 ± 14 112 ± 13 68 ± 14 95 ± 11
Eye 
Involvement 




120 ± 14 < 0.001 85 ± 13 0.001 114 ± 13 < 0.001 69 ± 13 < 0.001 97 ± 10 < 0.001




0 118 ± 17 0.158 83 ± 14 0.012 112 ± 13 0.037 68 ± 14 0.378 95 ± 11 0.021
1 112 ± 20 82 ± 15 107 ± 18 64 ± 14 91 ± 13
2+ 104 ± 18 76 ± 7 100 ± 18 55 ± 13 84 ± 12
Non-ocular 
Episodes
No 116 ± 14 0.069 76 ± 12 0.864 112 ± 20 0.472 67 ± 14 0.358 93 ± 11 0.286
Yes 109 ± 18 76 ± 15 108 ± 18 64 ± 14 89 ± 13
*Based on GEE analysis. † RRMS: Relapsing remitting multiple sclerosis, PPMS: Primary progressive multiple 
sclerosis, SPMS: Secondary progressive multiple sclerosis, PRMS: Progressive with relapsing multiple sclerosis
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significantly associated with disease duration 
and EDSS score 21. Feng et al., 22 evaluated 
peripapillary RNFL thickness in 12 MS patients 
and compared it to healthy individuals using high 
quality spectral-domain OCT. They concluded 
that the mean RNFLT was significantly lower in 
patients with MS compared to controls. Also MS 
patients with ON had significantly thinner RNFL 
compared to those without ON. 
Conclusion
We found that RNFLT decreases in MS patients 
and its reduction is related to the duration and 
type of disease as well as history and number 
of ON episodes. Therefore measuring RNFLT 
may help in estimating the progress of MS 
and can potentially be included as a part of 
patients’ follow up protocol.
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